EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting Hepatocellular Carcinoma: Schisandrin A Triggers Mitochondrial Disruption and Ferroptosis

Lin-Wei He, Chang-Jie Lin, Lin-Jun Zhuang, Yi-Hui Sun, Ye-Cheng Li, Zhen-Yu Ye

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.70010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Lin-Wei He und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Second Affiliated Hospital of Soochow University, Souzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Ferroptosis, Carcinoma, Hepatocellular, Liver Neoplasms, Reactive Oxygen Species. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, the Science Foundation of Jiangsu Health Commission, the Postgraduate Research and Practice Innovation Program of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The main focus of this research was to examine SchA's role in the hepatocellular carcinoma (HCC) development. LO2 and Huh7 cell viability were assessed using the MTT assay. The experiments included flow cytometry, colony formation, transwell, wound healing, and immunofluorescence assays to evaluate apoptosis levels, cells colony‐forming ability, ROS levels, invasion and migration ability, and mitochondrial membrane potential. Biochemical kits was utilized for checking the ATP, mitochondrial DNA, MDA, GSH, and Fe 2+ levels in the Huh7 cells, and western blot for measuring the ferroptosis and AMPK/mTOR related‐protein expression levels. The MTT assay demonstrated that SchA significantly reduced the vitality of Huh7 cells ranging from 10 to 50 μM, whereas it exhibited no discernible impact on LO2 cells. Additionally, SchA significantly inhibited colony‐forming ability, invasion ability, and migration ability within the concentration range of 10 to 50 μM, with a reduction of 68% in colony formation at 50 μM. SchA also induced apoptosis in a dose‐dependent manner. Moreover, SchA was observed to significantly elevate ROS levels dose‐dependently, down‐regulate mitochondrial membrane potential (JC‐1) at 20 and 50 μM, and reduce the levels of ATP and mtDNA dose‐dependently. Various concentrations of SchA resulted in a notable elevation in MDA and Fe 2+ levels as well as ACSL4 protein expression, accompanied by a reduction in GSH level and the protein expression of GPX4 and SLC7A11. Furthermore, SchA induced the activation of the AMPK/mTOR pathway in Huh7 cells, as evidenced by the increased phosphorylation level of AMPK and decreased phosphorylation level of mTOR. SchA might inhibit the progress of HCC through mitochondrial ferroptosis and dysfunction mediated by AMPK/mTOR pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisCarcinoma, HepatocellularLiver NeoplasmsReactive Oxygen SpeciesMembrane Potential, MitochondrialLignansCyclooctanesHumansCell Line, TumorPolycyclic CompoundsMitochondriaCell MovementApoptosisTOR Serine-Threonine KinasesCell SurvivalAMP-Activated Protein KinasesSignal Transduction

Stichwörter der Autor:innen

AMPK/mTOR pathwaySchisandrin Aapoptosisferroptosishepatocellular carcinomamitochondrial dysfunctionreactive oxygen species

Substanzen

Reactive Oxygen SpeciesLignansCyclooctanesPolycyclic CompoundsTOR Serine-Threonine KinasesAMP-Activated Protein Kinases

Autor:innen und Institutionen

  • Department of General Surgery, The Second Affiliated Hospital of Soochow University, Souzhou, Jiangsu, China.

Förderung

  • the National Natural Science Foundation of China
  • the Science Foundation of Jiangsu Health Commission
  • the Postgraduate Research and Practice Innovation Program of Jiangsu Province
  • the Science Projects of Suzhou Technology Bureau
  • the Found of Suzhou Introduced Team of Clinical Medical Experts
  • State Key Laboratory of Radiation Medicine and Protection
  • Talent research project of Suzhou Gusu Health Talents Program
  • The first "Nuclear Medical Science and Technology Innovation" Nuclear Medical Science and Technology Innovation plan project

Zitieren

APA

He, L. W., Lin, C. J., Zhuang, L. J., Sun, Y. H., Li, Y. C., & Ye, Z. Y. (2024). Targeting Hepatocellular Carcinoma: Schisandrin A Triggers Mitochondrial Disruption and Ferroptosis. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70010

Vancouver

He LW, Lin CJ, Zhuang LJ, Sun YH, Li YC, Ye ZY. Targeting Hepatocellular Carcinoma: Schisandrin A Triggers Mitochondrial Disruption and Ferroptosis. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.70010

BibTeX
@article{He2024,
  author = {He, Lin-Wei and Lin, Chang-Jie and Zhuang, Lin-Jun and Sun, Yi-Hui and Li, Ye-Cheng and Ye, Zhen-Yu},
  title = {Targeting Hepatocellular Carcinoma: Schisandrin A Triggers Mitochondrial Disruption and Ferroptosis},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.70010}
}
Kostenlos starten →